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Differentiated cells can be reprogrammed to form pluripotent embryonic stem cell-like cells by ectopic
expression of four transcription factors. In this issue of Cell Stem Cell, Liu et al. (2009) demonstrate that
a similar transition can be achieved by culturing retinoblastoma-deficient mouse embryonic fibroblasts in
suspension.
DOI 10.1016/j.stem.2009.03.011Embryonic stem cells (ESCs) are derived
from the culture of blastocyst-stage
embryos, exhibit infinite proliferative
potential, and can remain pluripotent in
the presence of appropriate exogenous
signals. Upon reintroduction into blasto-
cysts, murine ESCs support the genera-
tion of chimeric mice capable of transmit-
ting ESC-derived genetic information to
offspring. During embryogenesis, non-
pluripotent somatic stem cells arise that
are committed to the formation of only
a limited array of cell types. In adulthood,
highly specialized somatic stem cells,
typically present in small numbers, are
believed to sustain tissue maintenance
and also mediate repair processes in
some tissues.
For a long time the sequence ‘‘ES cell/
committed stem cell/differentiated cell’’
was considered irreversible in mammals.
However, this view was challenged by
experiments demonstrating that the
genome of adult, differentiated cells could
be reprogrammed to support pluripotency
when combined with an enucleated
oocyte by nuclear transfer or an ESC by
cell fusion (Wilmut et al., 1997; Tada
et al., 2001). In two seminal papers, Yama-
naka and colleagues showed that mouse
and human fibroblasts can be reprog-
rammed to form ESC-like cells by the
ectopic expression of only four transcrip-
tion factors:Oct3/4,Sox2,Klf4, andc-Myc
(Takahashi and Yamanaka, 2006; Takaha-
shi et al., 2007). The requirement for some
of these factors could be alleviated by
chemically interfering with chromatin
modification or signal transduction path-
ways, and reprogramming of other adult
lineages has also been demonstrated
(reviewed in this issue by Feng et al.,
2009). These so-called induced pluripo-tent stem cells (iPSCs) express ESC-
specific markers. iPSCs can differentiate
into many cell types in teratomas and
contribute to the formation of germline-
competent chimeric mice upon injection
into blastocysts (reviewed in Maherali
and Hochedlinger, 2008).
The report from Douglas Dean and
colleagues in this issue of Cell Stem Cell
represents an exciting extension of this
work (Liu et al., 2009). The authors demon-
strate that reprogramming of differenti-
ated cells into ESC-like cells can occur
spontaneously by specific culture condi-
tions without the need for ectopic expres-
sion of transcription factors to induce
pluripotency. They initially used mouse
embryonic fibroblasts (MEFs) that were
devoid of all three retinoblastoma (Rb)
gene family members, Rb, p107, and
p130. The products of these genes collec-
tively regulate the activity of E2F transcrip-
tion factors and are essential for proper
control of the G1/S transition of the cell
cycle (Cobrinik, 2005). Loss of this mech-
anism is a frequent if not mandatory step
in tumorigenesis. Triple knockout (TKO)
MEFs do not undergo senescence and
do not stop proliferating when cultures
reach confluence. Instead, the authors
show that mutant cells detached from the
culture dish surface and formed floating
spheres that resembled embryoid bodies
that arise when ESCs are deprived of
anchorage. Cells within TKO spheres ex-
pressed ESC-specific markers, including
Yamanaka’s reprogramming transcription
factors, Oct4, Sox2, Klf4, and c-Myc.
Spheres also exhibited hallmarks of
multilineage differentiation capacity, as
markers indicative of cardiac, muscle,
hematopoietic, endothelial, and neuronal
lineageswere also detected, via both RNACell Stem Cand protein expression assays. Remark-
ably, a side population (SP) of Hoechst
dye excluding highly tumorigenic cells
was also isolated from the TKO spheres.
The SP population expressed, in addition
to ESC markers, hallmarks associated
with cancer stem cells such as CD44,
CD133, Tert, and Abcg2. Thus, differenti-
ated Rb protein-deficient MEFs exhibit
an amazing degree of plasticity: when
deprived of adherence, conditions are
created that stimulate some cells to re-
express ESC markers, and at least a
subset of this population adopts charac-
teristics of cancer stem cells.
The observations of Dean and col-
leagues are highly intriguing but also raise
a host of questions. First, to what extent
did the reprogramming of MEFs rely on
the absence of Rb proteins? The authors
demonstrate that single mutant MEFs
devoid of only Rb, which retain contact
inhibition, could be induced to form
spheresbyscraping thecellsoff theculture
surfaces andculturing them in suspension.
Rb-deficient spheres were indistinguish-
able fromTKOspheres that spontaneously
developed upon confluency. Furthermore,
even wild-type MEFs could be forced to
form spheres, suggesting that reprogram-
ming did not depend on the loss of Rb
proteins. Another question raised by the
current findings is whether a specific
population of iPSCs is indeed present in
the spheres, and if so, to what extent they
resemble ESCs. The presence of iPSCs
is strongly suggested by the observed
expression of typical ESC genes as well
as markers representative of the three
germ layers and differentiated cells. It is
likely that such cells originated fromplurip-
otent stem cells, but it remains possible
that multiple primitive populations withell 4, April 3, 2009 ª2009 Elsevier Inc. 279
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source of the individual differentiated
lineages that arose. Indeed, injection of
spheres into nude mice did not form tera-
tomas, which are typically observed after
the transfer of ESCsor iPSCs. TheSP frac-
tion isolated from the spheres was highly
tumorigenic, but if this subpopulation
indeed comprised ESC-like cells, why did
the tumors only show neuronal differentia-
tion and not cartilage, muscle, bone,
etc., as seen in ESC-derived teratomas?
Furthermore, attempts to isolate iPSC lines
fromsphereshave failed thus far.Basedon
these deficiencies, the authors do not
claim that the spheres contain iPSCs. It is
possible, rather, that the ESC-like cells
arising in spheres may not have achieved
the full autonomy of truly pluripotent
ESCs, and instead remain dependent
on a specific microenvironment. Intimate
cell-cell contacts that are present within
the sphere structures and are lost upon
culturing under adherent conditions may
provide essential maintenance cues.
Thus, the suspension culture of MEFs
may induce niches that are required to
both induce and maintain the reprogram-
ming of the subset of cells that adoptFishing for a WNT
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Novel insight intocancerbiologyhascome
from advances in the stem cell field, with
the concept of a cancer stem cell suggest-
ing candidate pathways used to target
small populations of tumor cells resistant
to standard therapies. But the analogy
can work both ways, and signaling mech-
anisms that modulate tumor cell pheno-
types might also be applied to regenera-
280 Cell Stem Cell 4, April 3, 2009 ª2009 Elcharacteristics of iPSCs and cancer stem
cells.
The findings of Liu et al. are important
because they add to the ongoing discus-
sion of the origin and significance of
stem cells in tumor development (dis-
cussed in Jordan, 2009). One current
view suggests that cancer arises from
(epi)genetic transformation of normal
stem cells into cancer stem cells that
support tumor growth, sustain metas-
tasis, and are responsible for treatment
failure. An alternative view is that tumor
cells can originate fromdifferentiated cells
and that the developing tumor creates
niches where differentiated tumor cells
become reprogrammed to adopt stem
cell characteristics. This second concept
is mirrored in the plant kingdom, where
the sprouting of roots and shoots relies
on the creation of novel stem cell
niches in a context of differentiated cells
(Scheres, 2007). The current work of Liu
et al. suggests that a similar mechanism
may operate during tumor development
in animals. Finally, should it be possible
to culture iPSC lines from the spheres
described by the authors, this method
may lead to safer protocols for derivation-PGE2 Link:
ht in the Stem Cell
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are each associated with stem cell act
(2009)use thezebrafishmodel to reveal
ys via b-catenin, enhancing stem cell p
tive medicine. This insight is one of two
lessons learned from a study investigating
how prostaglandins (PGE2) modulate the
WNT signaling pathway (Goessling et al.,
2009), published recently in Cell.
Familial adenomatous polyposis (FAP)
is a condition characterized by hundreds
of benign colonic polyps, some of which
eventually progress to colon cancer. FAP
sevier Inc.of iPSCs to be exploited in regenerative
medicine and gene therapy of inherited
disease.
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ivity in the hematopoietic system. In
aconservedPKA-dependentmech-
roliferation and tissue regeneration.
is caused by mutations of the APC gene,
a tumor suppressor that along with Axin,
GSK3b, and CK1 comprise the ‘‘destruc-
tion complex,’’ which limits the accumula-
tion of stable, typically proproliferative
b-catenin. In an early case report, Waddell
and Loughry (1983) observed that polyps
were largely eradicated in several FAP
patients given sulindac, an NSAID shown
